(AGENPARL) – SILVER SPRING gio 27 aprile 2023 The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to the clinical development of gene therapy products for rare diseases (excluding hematology/oncology products).
Fonte/Source: http://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/otat-town-hall-clinical-development-gene-therapy-products-rare-diseases-02072023